Biomarkers of neurodegenerative diseases

Articles in the same Issue

1. Editorial
2. Biomarkers of neurodegenerative diseases
3. Reviews
4. CSF biomarkers in neurodegenerative diseases
5. Tau and p-tau as CSF biomarkers in dementia: a meta-analysis
6. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease
7. The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease
8. Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease
9. Parkinson's disease – the continuing search for biomarkers
10. α-Synuclein in Parkinson disease and other neurodegenerative disorders
11. S100B protein in neurodegenerative disorders
12. Inflammatory and structural biomarkers in acute traumatic spinal cord injury
13. Homocysteine: a biomarker in neurodegenerative diseases
14. Editorial
15. ROMA or death: advances in epithelial ovarian cancer diagnosis
16. Review
17. Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays
18. General Clinical Chemistry and Laboratory Medicine
19. Quality indicators and specifications for key analytical-extranalytical processes in the clinical laboratory. Five years’ experience using the Six Sigma concept
20. Determination of oxidative and occupational stress in palliative care workers
21. Effect of cigarette smoking on plasma homocysteine concentrations
22. Erythrocyte membrane protein analysis by sodium dodecyl sulphate-capillary gel electrophoresis in the diagnosis of hereditary spherocytosis
23. Evaluation of hematological parameters on admission for the prediction of 7-day in-hospital mortality in a large trauma cohort
24. Platelet function testing in hirudin and BAPA anticoagulated blood
25. Evaluation of the iChem^® Velocity™ Urine Chemistry Analyzer in a hospital routine laboratory
26. Crystalluria: prevalence, different types of crystals and the role of infrared spectroscopy
27. Cancer Diagnostics
28. The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
29. Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population
30. Cardiovascular Diseases
31. APOA5 −1131T/C polymorphism is associated with coronary artery disease in a Chinese population: a meta-analysis
32. Assessment of the nickel-albumin binding assay for diagnosis of acute coronary syndrome
33. Letters to the Editor
34. AGER gene -374T>A (rs1800624) polymorphism is not associated with the severity of non-diabetic coronary artery disease in Han Chinese
35. Some lessons learned from using medium scale genotyping techniques in pharmacogenetic research
36. Improved neopterin ELISA kit: a good compromise between HPLC results and clinical practice
37. Cross-reactivity of 25-hydroxy vitamin D2 from different commercial immunoassays for 25-hydroxy vitamin D: an evaluation without spiked samples
38. Modulated human maternal and premature neonatal erythrocyte membrane enzyme activities in relation to the mode of delivery: in vitro restoration with L-Carnitine